Histone modifications and cancer: biomarkers of prognosis?

Am J Cancer Res

Department of Environmental Medicine, New York University School of Medicine Tuxedo, New York 10987, USA.

Published: October 2012

Epigenetic dysregulation is being increasingly recognized as a hallmark of cancer. Post-translational modifications of histones, in particular, are known to play important roles gene expression alterations in cancer development and progression. Given their key involvement in the various stages of carcinogenesis, histone modifications are also being explored as potential biomarkers of disease progression and prognosis. This review will therefore discuss the role of histone modifications in cancer biology and will explore their prognostic potential.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433108PMC

Publication Analysis

Top Keywords

histone modifications
12
modifications cancer
8
cancer
4
cancer biomarkers
4
biomarkers prognosis?
4
prognosis? epigenetic
4
epigenetic dysregulation
4
dysregulation increasingly
4
increasingly recognized
4
recognized hallmark
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!